✦ LIBER ✦

Risk-Adapted Melphalan and Stem Cell Transplant for Systemic Light Chain Amyloidosis: A Single Institution Experience

✍ Scribed by Landau, Heather; Hassoun, Hani; Bello, Christina; Chou, Joanne; Devlin, Sean; Giralt, Sergio A.; Comenzo, Raymond

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High Dose Melphalan and Autologous Stem

✍ Tsukada, Nobuhiro; Miyazaki, Kanji; Abe, Yu; Sekine, Rieko; Nakagawa, Yasunori; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Risk-adapted autologous stem cell transp

✍ Adam D. Cohen; Ping Zhou; Joanne Chou; Julie Teruya-Feldstein; Lilian Reich; Han 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Maintained Hematologic and Organ Respons

✍ H.J. Landau; H. Hassoun; M.A. Rosenzweig; C. Bello; E. Hoover; E. Riedel; R.L. C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Long-Term Outcomes of Patients With Syst

✍ Landau, Heather; Fein, Daniel; Hassoun, Hani; Bello, Christina; Chou, Joanne; De 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Serum free light-chain responses after h

✍ Sanchorawala, V; Seldin, D C; Magnani, B; Skinner, M; Wright, D G 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Induction Bortezomib in AL Amyloidosis F

✍ Scott, Emma C.; Heitner, Stephen B.; Dibb, William; Meyers, Gabrielle; Smith, St 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 323 KB